Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Marina Biotech and Mirna Therapeutics enter agreement for microRNA-based drugs

Dec. 29, 2011

Immunomedics and UCB amend epratuzumab license agreement

Dec. 29, 2011

ProteoTech and GSK enter agreement

Dec. 28, 2011

Karo Bio and Pfizer to jointly develop new drugs for autoimmune diseases

Dec. 28, 2011

Japan Tobacco and Gilead Sciences enter licensing agreement

Dec. 28, 2011

ImmunoGen and Lilly enter collaboration for antibody-based anticancer therapeutics

Dec. 23, 2011

Affibody and Nuclisome join forces to develop cancer therapeutics

Dec. 23, 2011

NewGen Therapeutics acquires targeted oncology programs

Dec. 22, 2011

AbGenomics to regain rights to immunotherapeutic for psoriasis and other immunological diseases

Dec. 22, 2011

Hanmi and Kinex sign Orascovery licensing agreement

Dec. 22, 2011

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...